Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOCILIZUMAB-BAVI: 36 Adverse Event Reports & Safety Profile

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit
36
Total FAERS Reports
3 (8.3%)
Deaths Reported
20
Hospitalizations
36
As Primary/Secondary Suspect
4
Life-Threatening
Prescription
Status

FDA Application: 761354 ·

First Report: 20230613 · Latest Report: 20250808

What Are the Most Common TOCILIZUMAB-BAVI Side Effects?

#1 Most Reported
Product use in unapproved indication
9 reports (25.0%)
#2 Most Reported
Off label use
8 reports (22.2%)
#3 Most Reported
Myelosuppression
4 reports (11.1%)

All TOCILIZUMAB-BAVI Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Product use in unapproved indication 9 25.0% 1 4
Off label use 8 22.2% 1 5

Who Reports TOCILIZUMAB-BAVI Side Effects? Age & Gender Data

Gender: 56.4% female, 43.6% male. Average age: 62.4 years. Most reports from: CN. View detailed demographics →

Is TOCILIZUMAB-BAVI Getting Safer? Reports by Year

YearReportsDeathsHosp.
2023 5 0 5
2024 11 0 5
2025 13 2 9

View full timeline →

What Is TOCILIZUMAB-BAVI Used For?

IndicationReports
Rheumatoid arthritis 12
Prophylaxis 5

Official FDA Label for TOCILIZUMAB-BAVI

Official prescribing information from the FDA-approved drug label.